3AN-12594-50599
4 vaccinations
1 coded response
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 189 / PA
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Dose 1 — Moderna
-
2021-01-10
Registered in v-safe
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-05
Dose 2 — Moderna
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-08-08
-
2021-11-05
Dose 3 — Moderna
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Medical counselling, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): Midwife careMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-16
-
2022-09-22
Dose 4 — Pfizer-BioNTech
- 2022-09-24
- 2022-09-25
- 2022-09-27
- 2022-09-28
- 2022-09-29
-
2022-12-24
Health check-in — 3 months, dose 4Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had covidAdult check-in · check-in free text available
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-05 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Release 12 — 3 months, dose 4
Symptoms: Had covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release